Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Lack of news

"Nobody invested in PTSC for the BoD or the Company. They invested in the MMP."

How has the BoD enhanced the monetization of the MMP and what has been the result of those efforts vis-a-vis shareholder value, over the short-term, mid-term, and long-term?

Thank you.

Share
New Message
Please login to post a reply